Watertown, Mass, December 13, 2023 – In 2023, Exergen Corporation has marked a year of extraordinary achievements and significant global expansion. Renowned for its highly innovative temperature measurement technologies, Exergen has been instrumental in advancing medical thermometry, making it an essential part of healthcare routines worldwide.

Global Footprint and Technological Innovations
Exergen’s CEO and founder, Dr Francesco Pompei, says: “Exergen’s international expansion has been impressive, with strategic partnerships and distribution agreements with countries such as Brazil, Bolivia, Peru, Chili, Costa Rica, Argentina, UAE, Puerto Rico, Jordan, Gaza and the West Bank, UAE, Bangladesh, Afghanistan, Myanmar and Croatia amongst others. As a result of these collaborations, Exergen’s advanced Temporal Artery Thermometers have been introduced to many new healthcare sectors.”

An exciting development is the upcoming launch of a two-point verification kit for the TAT-5000S-EC Temporal Artery Thermometer, meeting Germany’s strict regulatory standards. This innovation exemplifies Exergen’s commitment to accuracy and reliability in temperature measurement. And of course the long awaited launch of TempoTherm, the introduction of the temporal artery thermometer for consumers in Europe.

Recognition in Healthcare
Exergen’s impact is evident in the healthcare sector, as reflected in Newsweek’s 2024 list of top U.S. hospitals, where the top 150 hospitals use Exergen Temporal Artery Thermometers (TAT-5000(S)). Next to that the list of 15 Healthcare Systems identified by Fortune Magazine as the being the ultimate top. All 15 also work with Exergen Tat LINE. This acknowledgment underlines the thermometer’s reliability and its critical role in patient care.

The Importance of Regular Temperature Monitoring
With the world becoming more health-conscious, regular monitoring of body temperature has become crucial. Exergen’s Temporal Artery Thermometers, known for their ease of use, reliability, and accuracy, are an ideal tool for this purpose. Checking one’s temperature twice daily with the Temporal Artery Thermometer ensures timely detection and response to health changes, making it an essential practice in today’s healthcare environment.

New Horizons in Thermometry
In order to obtain very accurate temperature measurements, it is not necessary to provide the Temporal Artery Thermometer with a protective cap. However, there are situations where this may be relevant, such as when treating patients who pose a high risk of cross-contamination. This is why the launch of the TAT-2000C Temporal Artery Thermometer with removable cap marks a new era in temperature screening, particularly in remote medical posts and mass screenings. The removable caps provide a hygienic solution, enhancing the efficiency of temperature monitoring in various settings.

Key Healthcare Trends of 2024
As the healthcare sector undergoes a significant transformation in 2024, driven by technological advancements and a shift towards patient-centric care, regular health monitoring, especially temperature checks, has become more critical than ever. Dr. Francisco Pompei emphasizes the growing importance of reliable tools like the Exergen Temporal Artery Thermometer in this evolving landscape.

In 2024, these trends will define the healthcare market:

1. AI-Driven diagnostics and treatments: AI’s role in enhancing early disease detection and personalized treatment plans underscores the need for regular temperature checks at home to catch early signs of illness.
2. Telemedicine’s global domination: The rise of virtual health consultations necessitates the use of self-monitoring tools. Regular temperature checks provide critical data for these online interactions.
3. Wearable and connected health tech: Wearables monitor various health metrics, and adding temperature checks to daily routines complements these devices for a more comprehensive health assessment.
4. Remote patient monitoring (RPM): RPM devices require supplementary data for timely interventions. Regular temperature monitoring provides these essential data points.
5. 3D Bioprinting: Patients involved in 3D bioprinting trials need to closely monitor their health, including temperature, to quickly identify any changes.
6. Decentralized clinical trials: Easy-to-use health monitoring tools, like the Exergen Temporal Artery Thermometer, are crucial for participants in remote trials for consistent data reporting.
7. Gene editing and CRISPR: Patients undergoing gene therapies need regular temperature monitoring to ensure appropriate bodily responses.
8. Digital therapeutics: As digital platforms become more prevalent in treatment, regular temperature monitoring becomes an integral part of managing health digitally.
9. Blockchain in healthcare: Reliable tools like the Exergen Temporal Artery Thermometer contribute accurate health data to secure blockchain platforms.
10. Holistic health and preventive medicine: Preventative approaches in healthcare emphasize monitoring key health indicators, like body temperature, to detect issues early.

“Next year will be extremely exciting as we will launch new thermometers that are highly focused on connectivity, improved ease of use and more innovative functionality,” said Dr Francisco Pompei. “Connectivity will become the gamechanger in our market and we are completely focused on turning this into reality,” he added.

The year 2024 will once again prove that Exergen’s Temporal Artery Thermometers are indispensable tools for maintaining health and well-being, making twice-daily temperature checks a recommended routine under these evolving conditions.

About Exergen
Exergen Corporation, the leader in non-invasive temperature measurement technologies for industrial and medical applications, delivers non-invasive temperature meters at lower costs, with higher accuracy, less process control and higher reliability than previously possible. With its award-winning arterial thermometer, Exergen is known in both the healthcare and consumer markets. The company was founded by MIT educated and Harvard researcher Dr. Francesco Pompei, who owns more than 70 patents. Exergen Corporation is headquartered in Watertown, Massachusetts, United States.

Media Contact:
Christina Guilbert Klaubert
Cguilbert@exergen.com
www.exergen.com